Pauline Evers

862 total citations
10 papers, 288 citations indexed

About

Pauline Evers is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Pauline Evers has authored 10 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Pauline Evers's work include Cancer Immunotherapy and Biomarkers (5 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Immunotherapy and Immune Responses (2 papers). Pauline Evers is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Immunotherapy and Immune Responses (2 papers). Pauline Evers collaborates with scholars based in Netherlands, Germany and Slovakia. Pauline Evers's co-authors include Jens Atzpodien, C.R. Franks, Peter Palmer, R. Oskam, Gerda Roest, M. Hadam, Michelle Hendriks, Diana Delnoij, Jany JDJM Rademakers and Marieke Zegers and has published in prestigious journals such as Cancer, European Journal of Cancer and Cancer Letters.

In The Last Decade

Pauline Evers

10 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pauline Evers Netherlands 8 149 120 64 54 43 10 288
Kim Ryan Australia 3 225 1.5× 49 0.4× 39 0.6× 29 0.5× 61 1.4× 5 335
María José Lecumberri Spain 8 224 1.5× 123 1.0× 46 0.7× 38 0.7× 93 2.2× 14 333
Nicole E. James United States 12 91 0.6× 71 0.6× 40 0.6× 75 1.4× 53 1.2× 32 298
Asif Talukder United States 11 222 1.5× 67 0.6× 90 1.4× 126 2.3× 126 2.9× 19 443
Berta Hernández Spain 10 243 1.6× 114 0.9× 26 0.4× 43 0.8× 77 1.8× 17 352
Elissa McMurtrie Canada 11 149 1.0× 111 0.9× 71 1.1× 41 0.8× 20 0.5× 15 383
Valeria Stati Italy 11 182 1.2× 27 0.2× 43 0.7× 61 1.1× 99 2.3× 25 319
Campbell Tiley Australia 10 159 1.1× 36 0.3× 25 0.4× 78 1.4× 35 0.8× 25 351
Fharat Raja United Kingdom 7 155 1.0× 22 0.2× 45 0.7× 85 1.6× 43 1.0× 11 307
Débora S. Bruno United States 12 215 1.4× 77 0.6× 32 0.5× 51 0.9× 128 3.0× 45 352

Countries citing papers authored by Pauline Evers

Since Specialization
Citations

This map shows the geographic impact of Pauline Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pauline Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pauline Evers more than expected).

Fields of papers citing papers by Pauline Evers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pauline Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pauline Evers. The network helps show where Pauline Evers may publish in the future.

Co-authorship network of co-authors of Pauline Evers

This figure shows the co-authorship network connecting the top 25 collaborators of Pauline Evers. A scholar is included among the top collaborators of Pauline Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pauline Evers. Pauline Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bastiaenen, Vivian P., Charlotte E.L. Klaver, Niels F. M. Kok, et al.. (2019). Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial. BMC Cancer. 19(1). 254–254. 20 indexed citations
2.
Tsigkos, Stelios, Segundo Mariz, Laura Fregonese, et al.. (2014). Use of biomarkers in the context of orphan medicines designation in the European Union. Orphanet Journal of Rare Diseases. 9(1). 13–13. 6 indexed citations
3.
Zegers, Marieke, et al.. (2013). Improving cancer patient care: development of a generic cancer consumer quality index questionnaire for cancer patients. BMC Cancer. 13(1). 203–203. 39 indexed citations
5.
Palmer, Peter, Pauline Evers, R. Oskam, et al.. (1992). Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma. European Journal of Cancer. 28(6-7). 1038–1044. 56 indexed citations
6.
Kirchner, Hartmut, Pauline Evers, Márta Szamel, et al.. (1991). The development of neutralizing antibodies in a patient receiving subcutaneous recombinant and natural interleukin-2. Cancer. 67(7). 1862–1864. 20 indexed citations
7.
Kirchner, H., et al.. (1990). Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience.. PubMed. 2(3). 145–54. 23 indexed citations
8.
Atzpodien, Jens, Pauline Evers, E Lopez-Hänninen, et al.. (1990). Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study.. PubMed. 2(1). 18–26. 51 indexed citations
9.
Zelle, B., Ad Geurts van Kessel, Jan de Wit, et al.. (1985). Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. Human Genetics. 70(4). 337–340. 25 indexed citations
10.
Sluyser, Mels, Pauline Evers, & J. Hilgers. (1985). Translocations involving chromosome 1 in hormone-independent GR mouse mammary tumors. Cancer Letters. 27(2). 207–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026